These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36510178)

  • 1. The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa - a systematic literature review.
    Masuku SD; Lekodeba N; Meyer-Rath G
    BMC Public Health; 2022 Dec; 22(1):2321. PubMed ID: 36510178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review.
    Brouwer ED; Watkins D; Olson Z; Goett J; Nugent R; Levin C
    BMC Public Health; 2015 Nov; 15():1183. PubMed ID: 26612044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia: A Systematic Review.
    Walker IF; Garbe F; Wright J; Newell I; Athiraman N; Khan N; Elsey H
    Value Health Reg Issues; 2018 May; 15():12-26. PubMed ID: 29474174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review.
    Afroz A; Alramadan MJ; Hossain MN; Romero L; Alam K; Magliano DJ; Billah B
    BMC Health Serv Res; 2018 Dec; 18(1):972. PubMed ID: 30558591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic burden of treating uncomplicated hypertension in Sub-Saharan Africa: a systematic literature review.
    Gnugesser E; Chwila C; Brenner S; Deckert A; Dambach P; Steinert JI; Bärnighausen T; Horstick O; Antia K; Louis VR
    BMC Public Health; 2022 Aug; 22(1):1507. PubMed ID: 35941626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of diabetes mellitus in Africa: a systematic review of existing literature.
    Mutyambizi C; Pavlova M; Chola L; Hongoro C; Groot W
    Global Health; 2018 Jan; 14(1):3. PubMed ID: 29338746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is fenofibrate a cost-saving treatment for middle-aged individuals with type 2 diabetes? A South African private-sector perspective.
    Wessels F
    Cardiovasc J Afr; 2010; 21(1):43-6. PubMed ID: 20224845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of liraglutide in type II diabetes: a systematic review.
    Zueger PM; Schultz NM; Lee TA
    Pharmacoeconomics; 2014 Nov; 32(11):1079-91. PubMed ID: 25052903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Care Resource Utilization in Adults Living With Type 1 Diabetes Mellitus in the South African Public Health Sector: Protocol for a 1-Year Retrospective Analysis With a 5-, 10-, and 25-Year Projection.
    Bhana S; Naidoo P; Pillay S; Variava E; Naidoo K; Rohitlall N; Sekhuthe L; Pauly B
    JMIR Res Protoc; 2023 Feb; 12():e44308. PubMed ID: 36780227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A total cost perspective of type 1 and 2 diabetes mellitus in two South African medical schemes servicing the public healthcare sector.
    Opperman AM; De Klerk M
    S Afr Med J; 2021 Jun; 111(7):635-641. PubMed ID: 34382546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies.
    Stegbauer C; Falivena C; Moreno A; Hentschel A; Rosenmöller M; Heise T; Szecsenyi J; Schliess F
    BMC Health Serv Res; 2020 Nov; 20(1):1043. PubMed ID: 33198734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.
    Korczak D; Dietl M; Steinhauser G
    GMS Health Technol Assess; 2011 Apr; 7():Doc02. PubMed ID: 21468290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic literature review of the costs of pregnancy in the US.
    Huynh L; McCoy M; Law A; Tran KN; Knuth S; Lefebvre P; Sullivan S; Duh MS
    Pharmacoeconomics; 2013 Nov; 31(11):1005-30. PubMed ID: 24158771
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.